Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lactic Acid SCHEMBL28122063 | 0.92 | TBXAS1 (0.62) | TBXAS1EGLN3 | |
| Bicarbonate SCHEMBL28296554 | 0.90 | TBXAS1 (0.70) | TBXAS1EGLN3 | |
| Oxalic Acid SCHEMBL1829969 | 0.88 | TBXAS1 (0.68) | TBXAS1EGLN3 | |
| Oxalic Acid SCHEMBL1829323 | 0.88 | TBXAS1 (0.68) | TBXAS1EGLN3 | |
| Acetic Acid SCHEMBL16341977 | 0.88 | TBXAS1 (0.68) | TBXAS1EGLN3 | |
| Lactic Acid SCHEMBL28507622 | 0.88 | TBXAS1 (0.68) | TBXAS1 | |
| Lactic Acid SCHEMBL28499294 | 0.86 | TBXAS1 (0.71) | TBXAS1 | |
| Lactic Acid SCHEMBL29271999 | 0.86 | TBXAS1 (0.71) | TBXAS1 | |
| Glycolic Acid SCHEMBL25294099 | 0.85 | TBXAS1 (0.64) | TBXAS1EGLN3 | |
| Pyruvate SCHEMBL27650226 | 0.85 | TBXAS1 (0.64) | TBXAS1EGLN3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1861364-B1 | PREPARATION OF AN ATORVASTATIN INTERMEDIATE USING A PAAL-KNORR CONDENSATION | C P PHARMACEUTICALS INTERNAT C V (US) | 2011-05-11 | — | — | EP | claimed |
| JP-2008533128-A | — | — | 2008-08-21 | — | — | JP | claimed |
| EP-1861364-A1 | PREPARATION OF AN ATORVASTATIN INTERMEDIATE USING A PAAL-KNORR CONDENSATION | Pfizer Science and Technology Ireland Limited (IE) | 2007-12-05 | — | — | EP | claimed |
| WO-2006097909-A1 | PREPARATION OF AN ATORVASTATIN INTERMEDIATE USING A PAAL-KNORR CONDENSATION | PFIZER SCIENCE AND TECHNOLOGY IRELAND LIMITED (IE) | 2006-09-21 | — | — | WO | claimed |
| EP-1861364-B1 | PREPARATION OF AN ATORVASTATIN INTERMEDIATE USING A PAAL-KNORR CONDENSATION | C P PHARMACEUTICALS INTERNAT C V (US) | 2011-05-11 | — | — | EP | disclosed |
| EP-1861364-A1 | PREPARATION OF AN ATORVASTATIN INTERMEDIATE USING A PAAL-KNORR CONDENSATION | Pfizer Science and Technology Ireland Limited (IE) | 2007-12-05 | — | — | EP | disclosed |
| WO-2006097909-A1 | PREPARATION OF AN ATORVASTATIN INTERMEDIATE USING A PAAL-KNORR CONDENSATION | PFIZER SCIENCE AND TECHNOLOGY IRELAND LIMITED (IE) | 2006-09-21 | — | — | WO | disclosed |